Greenphire, the global leader in clinical payment solutions, today announced expanded capabilities for its ClinCard solution, improving its ability to reimburse patients in more countries and currencies.
This expansion will further empower global research sites, providing flexible, convenient reimbursement methods to simplify and streamline clinical trial operations.
According to the U.S. National Institutes of Health (NIH), nearly 60 percent of the clinical trials being conducted today include sites outside of the U.S., a number that has increased more than five-fold since 2004.
“Engaging and retaining patients in clinical research is challenging, regardless of where the trial is located,” said Jim Murphy, CEO of Greenphire. “Expanding ClinCard’s capabilities provides a simplified, proven solution that meets market-specific requirements and reduces the burden of global clinical trial execution.”
Read the full article here.